急性肝损伤大鼠模型的血浆氨基酸代谢变化模式

以Ｄ－氨基半乳糖（Ｄ－Ｇａｌａｃｔｏｓａｍｉｎｅ,Ｄ－ＧａｌＮ）造成急性肝损伤（急性肝炎、急性肝坏死）大鼠模型后、对照观察了急性肝损伤大鼠血浆氨基酸的变化,建立了大鼠急性肝损伤时血浆氨基酸的变化模式并对其发生机理进行了探讨。大鼠血浆氨基酸的测定采用聚酰薄层荧光分析技术,其测定结果是：急性肝炎组,酪氨酸（Ｔｙｒ）、天冬氨酸（Ａｓｐ）、谷氨酰胺（Ｇｌｎ）和鸟氨酸（Ｏｒｎ）升高,精氨酸（Ａｒｇ）下降,其余氨基酸无显著变化。急性肝坏死组,除Ａｒｇ显著下降外,其余所有氨基酸都显著升高,而两组支链氨基酸（ＢＣＡＡ）／芳香族氨基酸（ＡＡＡ）克分子比值均显著下降。     

支链氨基酸对心肌缺血大鼠体内抗氧化系统的影响

用异丙肾上腺素（Ｉｓｏ）造成大鼠心肌缺血动物模型,观察支链氨基酸（ＢＣＡＡ）对大鼠心肌缺血损伤体内抗氧化系统及游离氨基酸的影响。结果表明,ＢＣＡＡ能明显降低体内的丙二醛（ＭＤＡ）水平,保护了体内谷胱甘肽过氧化物酶（ＧＳＨ－Ｐｘ）和超氧化物歧化酶（ＳＯＤ）的酶活力;并使心肌中谷氨酸、天冬氨酸水平显著升高,血清和心肌中丙氨酸水平显著提高。因此,给予ＢＣＡＡ对心脏缺血性损伤具有一定的防护效果。     

支链氨基酸对心肌缺血大鼠线粒体损伤的保护作用

目的和方法：本文用异丙肾上腺素（Ｉｓｏ） 造成大鼠心肌缺血动物模型,观察支链氨基酸（ＢＣＡＡ）对大鼠心肌缺血时线粒体结构和功能损伤的预防作用。结果：ＢＣＡＡ 能显著降低心肌缺血后心肌线粒体中丙二醛（ＭＤＡ） 水平、维持线粒体模平均微粘度（－η） 、线粒体呼吸链中细胞色素氧化酶及心肌肌球蛋白ＡＴＰａｓｅ活力。结论：给予ＢＣＡＡ对保护大鼠心肌线粒体的结构和功能免受缺血性损伤具有一定效果     

兔阑尾中一种新的21kD的钙结合蛋白的纯化与鉴定

纯化与鉴定了Ｂ淋巴细胞中一种新的分子量为２１ｋＤ的钙结合蛋白（ＣａＢＰ２１）。兔阑尾淋巴细胞匀浆经热变性,Ｐｈｅｎｙｌ－Ｓｅｐｈａｒｏｓｅ与ＤＥＡＥ－Ｓｅｐｈａｒｏｓｅ柱层析,自每１ｋｇ细胞沉积物中获得ＳＤＳ－ＰＡＧＥ均一的ＣａＢＰ２１５．３ｍｇ。ＨＣｌ水解后的酸性氨基酸（Ａｓｐ＋Ｇｌｕ）含量为２６％。如同大多数钙结合蛋白一样,Ｎ末端封闭阻止其进行Ｅｄｍａｎ降解。ＣａＢＰ２１中疏水性氨基酸（计Ｇｌｙ,不计Ｔｒｐ）约占４６％,碱性氨基酸１０％,酸性氨基酸与极性氨基酸约４４％。ＣａＢＰ２１有较高的Ｓｅｒ、Ｔｙｒ含量。肽谱分析等确证ＣａＢＰ２１为２个相同或相似亚基二聚体。以ＡｒｓｅｎａｚｏⅢ作Ｃａ２＋结合分析表明每分子ＣａＢＰ２１可结合４分子Ｃａ２＋,对Ｃａ２＋的结合常数约为１０－５ｍｏｌ／Ｌ。各种性质表明ＣａＢＰ２１是一种不同于其他已知钙结合蛋白的新钙结合蛋白。     

BRCA1基因结构及其在乳腺癌中的表达

利用ＭＰＣＲ技术从乳腺组织分离到抑癌基因ＢＲＣＡ１的ｃＤＮＡ片段,将此９１４ｂｐ的片段克隆进质粒ｐＵＣ１１８,并经全序列测定证实。序列分析表明,ＢＲＣＡＩｃＤＮＡ编码的肽链ＮＮ２－末端有一锌指结构,抑癌基因ＢＲＣＡＩ的产物可能是ＤＮＡ结合蛋白,ｃＤＮＡ序列存在两个变异位点：一个是第４０９位的Ｃ→Ａ（Ａｓｐ→Ｇｌｕ）：另一个是第８７９位的Ａ→Ｔ（ＭＩａ同义突变）。以该片段为探针,检测６例乳腺癌组织中ＢＲＣＡＩｍＩＭＡ表达,一例表达明显下降,一例没检测到表达的ｍＩＭＡ产物,说明一些乳腺癌组织的ＢＲＣＡ１基因转录水平降低     

测量细胞内吞过程中膜受体流动性的新方法

本文首次提出用ＡＢＣ（ＡｖｉｄｉｎＢｉｏｔｉｎＣｏｍｐｌｅｘ）法标记细胞膜受体,通过ＦＲＡＰ（ＦｌｕｏｒｅｓｃｅｎｃｅＲｅｃｏｖｅｒｙＡｆｔｅｒＰｈｏｔｏｂｌｅａｃｈｉｎｇ）技术,测量细胞内吞过程中受体流动性变化的方法。实验选择巨噬细胞ＣｏｎＡ受体,比较了用ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩＴＣ（ＡＢＣ法）和ＣｏｎＡ－ＦＩＴＣ（直接法）标记的膜表面ＣｏｎＡ受体荧光强度和内吞过程中受体的流动性测量结果。结果显示ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩＴＣ标记的巨噬细胞膜受体的平均荧光强度比用ＣｏｎＡ－ＦＩＴＣ标记的平均荧光强度高大约３倍;ＡＢＣ法标记的受体,测量结果误差小、灵敏度高;ＣｏｎＡ刺激１５ｍｉｎ后,巨噬细胞膜表面ＣｏｎＡ受体的扩散系数和荧光恢复率较静息状态时明显下降。讨论了两种标记方法对测量结果的影响     

鲫鱼视网膜谷氨酸受体和GABA受体在爪蟾卵母细胞中的表达

我们以两栖类卵母细胞为功能表达系统,通过注射鲫鱼（Ｃａｒａｓｓｉｕｓｃａｒａｓｓｉｕｓ）视网膜ｍＲＮＡ,利用电压箝及药物灌流手段,系统地研究了鲫鱼视网膜内氨基酸受体的类型和特征,结果如下：（１）Ｇｌｕ受体：ＫＡ可以诱发明显的去极化电流,而且Ｄｉａｚｏｘｉｄｅ能增强ＫＡ诱导的反应,这提示鲫鱼视网膜内某些Ｃｌｕ受体是ＡＭＰＡ选择性亚型（ＡＭＰＡ－ｐｒｅｆｅｒｒｉｎｇｓｕｂｔｙｐｅ）。（２）ＣＡＢＡ受体：ＧＡＢＡ能诱发一个快速、光滑的内向电流,绝大部分对ＧＡＢＡ的反应可被ｂｉｃｕｃｕｌｌｉｎｅ所压抑,而ＧＡＢＡ＿Ｂ受体的激动剂ｂａｃｌｏｆｅｎ则无任何作用,这提示,鲫鱼视网膜内大部分是ＧＡＢＡ＿Ａ受体。     

两例丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)重叠感染者的HCV核心区cDNA序列分析

从临床肝病患者中选择两例ＨＣＶ和ＨＢＶ重叠感染者ＨＳＱ和ＳＺＨ,他们血清中的生化指标丙氨酸转氨酶（ＡＬＴ）持续异常,肝活检病理示有严重的肝损伤。在ＡＬＴ异常期,血清学检测结果为ＨＢｓＡｇ、ＨＢｅＡｇ阳性,抗ＨＣＶＩｇＧ（包括Ｃ２２、Ｃ３３ｃ）阴性,但套式ＰＣＲ检测ＨＣＶＲＮＡ阳性,核心区ｃＤＮＡ序列分析发现该区有１个密码子（ＧＧＣｎｔ３８５—３８７）缺失,对应缺失的氨基酸是甘氨酸（ＧＬＹ）,从血清学检测和序列分析结果推测,在ＨＣＶ和ＨＢＶ重叠感染中,ＨＢＶ和ＨＣＶ均可处于持续复制状态,抗ＨＣＶＩｇＧ抗体阴性可能是ＨＣＶ的多蛋白前体翻译和病毒颗粒装配受到ＨＢＶ干扰的结果。     

ESR研究急性运动及恢复期大鼠RBCM脂流动性的改变

本文以大鼠递增负荷力竭性运动为模型,利用电子自旋共振（ＥＳＲ）技术测定急性运动中及不同时程恢复期红细胞膜（ＲＢＣＭ）脂流动性的改变。ＲＢＣＭ脂尾部流动性在短时间中等强度运动（三级负荷末）即有明显下降（Ｐ＜０．０５）,在运动后恢复期进行性加重,并于运动后１２ｈ达极显著改变（Ｐ＜０．０１）：此时膜脂头部流动性也明显下降（Ｐ＜０．０５）。之后二者均有恢复趋势,提示递增负荷力竭性运动对ＲＢＣＭ脂流动性有重要影响,并且ＲＢＣＭ脂流动性与膜功能相互作用,互相影响     

肾小球疾病儿童体内游离氨基酸含量的研究

为了研究小儿肾小球病变时体内游离氨基酸的代谢变化,采用丹酰氯聚酰胺薄层分析法研究了原发性肾病综合症（ＩＮＳ）８例、急性肾小球肾炎（ＡＧＮ）１２例、过敏性紫癜肾炎（ＡＰＮ）７例与正常对照组２９例的血清及红细胞内游离氨基酸含量的变化。结果表明：（１）此三种肾小球疾病,血清中苯丙氨酸（Ｐｈｅ）、脯氨酸（Ｐｒｏ）、色氨酸（Ｔａｐ）、赖氨酸（Ｌｙｓ）、甘氨酸（Ｇｌｙ）明显高于正常,导致酪／苯丙（Ｔｙｒ／Ｐｈｅ）、缬／甘（Ｖａｌ／Ｇｌｙ）等分子比降低,提示肾功能受损。（２）血清支链氨基酸（ＢＣＡＡ）的含量在ＩＮＳ中低于正常组（ｔ＝３．４８;Ｐ＜０．０１）,而在ＡＧＮ、ＡＰＮ中却高于正常组（ｔ分别为２．３３,２．３９,Ｐ＜０．０５）。（３）红细胞中丝氨酸（Ｓｒｅ）、苯丙氨酸（Ｐｈｅ）、色氨酸（Ｔｒｐ）、胱氨酸＋半胱氨酸（Ｃｙｓ）、天冬氨酸（Ａｓｐ）、谷氨酸（Ｇｌｕ）的含量ＡＰＮ组高于ＩＮＳ及ＡＧＮ,提示ＡＰＮ患儿中肾功能损害没有ＩＮＳ及ＡＧＮ严重。     

某些内科系统疾病患者血浆游离氨基酸的变化及意义

为了解某些内科系统疾病的血氨基酸代谢特点。测定１７０例９种内科系统急慢性疾病患者血浆游离氨基酸浓度,并分别与５８例健康人血浆氨基酸浓度作对比分析。９种疾病的血浆胱氨基酸浓度不同程度升高,以尿毒症病人最为显著,炎症性病人血浆苯丙、蛋、赖氨酸和苯丙／酪比值显著升高,丙、组、精、脯氨酸和支／芳比值显著降低;糖尿病和甲亢病人血浆总游离氨基酸、谷、丙、酪、赖和支链氨酸显著升高;糠尿病病人支／芳比值显著升高,表明不同疾病的血氨基酸浓度有特征性变化,炎症是导致血氨基酸代谢紊乱的重要因素     

Plasma amino acid imbalance in alcoholic liver cirrhosis

Plasma amino acid concentrations and plasma glucagon and serum insulin levels were studied in male patients with compensated alcoholic and nonalcoholic liver cirrhosis. Age, nutritional status, and liver function tests were similar in both groups; none of the patients presented hepatic encephalopathy. Plasma valine and leucine concentrations were lower, and tyrosine, higher in alcoholic than nonalcoholic liver cirrhosis. As a result, the molar ratios of branched-chain amino acids (BCAA) to aromatic amino acids (AAA) were reduced markedly in this group. Although correlation coefficients comparing BCAA/AAA ratios and KICG in alcoholic and nonalcoholic liver cirrhosis were similar, a steeper regression line was observed in alcoholics. Plasma glucagon and proline levels were significantly higher in alcoholic than nonalcoholic liver cirrhosis, the former correlated with AAA concentrations only in alcoholic liver cirrhosis, but not with BCAA levels. These results indicated that alcoholic liver cirrhosis presented a more deranged plasma amino acid pattern than nonalcoholic, and the amino acid imbalances, except for depressed BCAA and elevated proline, were derived, in part, from the hyperglucagonemia.     

Plasma amino acids in four models of experimental liver injury in rats

Summary We studied the plasma amino acid profiles in four models of hepatic injury in rats. In partially hepatectomized rats (65% of liver was removed) we observed significant increase of aromatic amino acids (AAA; i.e. tyrosine and phenylalanine), taurine, aspartate, threonine, serine, asparagine, methionine, ornithine and histidine. Branched-chain amino acids (BCAA; i.e. valine, leucine and isoleucine) concentrations were unchanged. In ischemic and carbon tetrachloride acute liver damage we observed extreme elevation of most of amino acids (BCAA included) and very low concentration of arginine. In carbon tetrachloride induced liver cirrhosis we observed increased levels of AAA, aspartate, asparagine, methionine, ornithine and histidine and decrease of BCAA, threonine and cystine. BCAA/AAA ratio decreased significantly in partially hepatectomized and cirrhotic rats and was unchanged in ischemic and acute carbon tetrachloride liver damage. We conclude that a high increase of most of amino acids is characteristic of fulminant hepatic necrosis; decreased BCAA/AAA ratio is characteristic of liver cirrhosis; and decrease of BCAA/AAA ratio may not be used as an indicator of the severity of hepatic parenchymal damage.Abbreviations BCAA branched-chain amino acids (i.e. valine, leucine and isoleucine) - AAA aromatic amino acids (i.e. tyrosine and phenylalanine)     

各型肝病患者红细胞内氨基酸检测的临床研究

本文对３０例正常人和１０８例各型肝病患者红细胞内氨基酸进行检测,结果显示,各型肝炎与正常人比较红细胞内氨基酸均表现不同程度的增高和降低。如正常人红细胞内１７种氨基酸的总量为３５５４．４７μｍｏｌ／Ｌ,支／芳比值３．０６±０．４０;急性肝炎总量３４２３．２５μｍｏｌ／Ｌ,支／芳比值２．４８±０．３０;慢性肝炎（轻度）总量３３２９．３３μｍｏｌ／Ｌ,支／芳比值２．３９±０．２２;慢性肝炎（中度）总量３２１９．３２μｍｏｌ／Ｌ,支／芳比值１．８３±０．４０;肝硬化总量３７６２．３３μｍｏｌ／Ｌ,支／芳比值１．３６±０．４１。     

Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury

Changes in plasma aromatic amino acids (AAA?=?phenylalanine, tryptophan, tyrosine) and branched chain amino acids (BCAA?=?isoleucine, leucine, valine) levels possibly influencing intracranial pressure (ICP) and cerebral oxygen consumption (SjvO(2)) were investigated in 19 sedated patients up to 14?days following severe traumatic brain injury (TBI). Compared to 44 healthy volunteers, jugular venous plasma BCAA were significantly decreased by 35% (p?相似文献   

Liver BCATm transgenic mouse model reveals the important role of the liver in maintaining BCAA homeostasis

Unlike other amino acids, the branched-chain amino acids (BCAAs) largely bypass first-pass liver degradation due to a lack of hepatocyte expression of the mitochondrial branched-chain aminotransferase (BCATm). This sets up interorgan shuttling of BCAAs and liver–skeletal muscle cooperation in BCAA catabolism. To explore whether complete liver catabolism of BCAAs may impact BCAA shuttling in peripheral tissues, the BCATm gene was stably introduced into mouse liver. Two transgenic mouse lines with low and high hepatocyte expression of the BCATm transgene (LivTg-LE and LivTg-HE) were created and used to measure liver and plasma amino acid concentrations and determine whether the first two BCAA enzymatic steps in liver, skeletal muscle, heart and kidney were impacted. Expression of the hepatic BCATm transgene lowered the concentrations of hepatic BCAAs while enhancing the concentrations of some nonessential amino acids. Extrahepatic BCAA metabolic enzymes and plasma amino acids were largely unaffected, and no growth rate or body composition differences were observed in the transgenic animals as compared to wild-type mice. Feeding the transgenic animals a high-fat diet did not reverse the effect of the BCATm transgene on the hepatic BCAA catabolism, nor did the high-fat diet cause elevation in plasma BCAAs. However, the high-fat-diet-fed BCATm transgenic animals experienced attenuation in the mammalian target of rapamycin (mTOR) pathway in the liver and had impaired blood glucose tolerance. These results suggest that complete liver BCAA metabolism influences the regulation of glucose utilization during diet-induced obesity.     

Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease

Background

Fatty liver is a major cause of obesity-related morbidity and mortality. The aim of this study was to identify early metabolic alterations associated with liver fat accumulation in 50- to 55-year-old men (n = 49) and women (n = 52) with and without NAFLD.

Methods

Hepatic fat content was measured using proton magnetic resonance spectroscopy (¹H MRS). Serum samples were analyzed using a nuclear magnetic resonance (NMR) metabolomics platform. Global gene expression profiles of adipose tissues and skeletal muscle were analyzed using Affymetrix microarrays and quantitative PCR. Muscle protein expression was analyzed by Western blot.

Results

Increased branched-chain amino acid (BCAA), aromatic amino acid (AAA) and orosomucoid were associated with liver fat accumulation already in its early stage, independent of sex, obesity or insulin resistance (p<0.05 for all). Significant down-regulation of BCAA catabolism and fatty acid and energy metabolism was observed in the adipose tissue of the NAFLD group (p<0.001for all), whereas no aberrant gene expression in the skeletal muscle was found. Reduced BCAA catabolic activity was inversely associated with serum BCAA and liver fat content (p<0.05 for all).

Conclusions

Liver fat accumulation, already in its early stage, is associated with increased serum branched-chain and aromatic amino acids. The observed associations of decreased BCAA catabolism activity, mitochondrial energy metabolism and serum BCAA concentration with liver fat content suggest that adipose tissue dysfunction may have a key role in the systemic nature of NAFLD pathogenesis.     

Increased Hippocampal Afterdischarge Threshold in Ketogenic Diet is Accompanied by Enhanced Kynurenine Pathway Activity

The efficacy of a ketogenic diet (KD) in controlling seizure has been shown in many experimental and clinical studies, however, its mechanism of action still needs further clarification. The major goal of the present study was to investigate the influence of the commercially available KD and caloric restriction (CR) on the hippocampal afterdischarge (AD) threshold in rats, and concomitant biochemical changes, specifically concerning the kynurenine pathway, in plasma and the hippocampus. As expected, the rats on the KD showed higher AD threshold accompanied by increased plasma β-hydroxybutyrate level compared to the control group and the CR rats. This group presented also lowered tryptophan and elevated kynurenic acid levels in plasma with similar changes in the hippocampus. Moreover, the KD rats showed decreased levels of branched chain amino acids (BCAA) and aromatic amino acids (AAA) in plasma and the hippocampus. No regular biochemical changes were observed in the CR group. Our results are analogous to those detected after single administrations of fatty acids and valproic acid in our previous studies, specifically to an increase in the kynurenine pathway activity and changes in peripheral and central BCAA and AAA levels. This suggests that the anticonvulsant effect of the KD may be at least partially associated with those observed biochemical alternations.

     

Effects of chronic oral branched-chain amino acid supplementation in a subpopulation of cirrhotics

Liver cirrhosis is characterized by low plasma levels of branched chain amino acids (BCAA) and high concentrations of aromatic amino acids (AAA), and this imbalance has been implicated in the pathogenesis of hepatic encephalopathy by the synthesis of altered neurotransmitters. Contrasting results on intravenous or oral BCAA efficacy and metabolic impact have already been reported, but studies reported in the literature were never longer than a few weeks. After oral administration of BCAA and a standard diet to 28 cirrhotic patients for 1 year, no modifications in plasma concentrations of BCAA could be observed up to 3 months of therapy. Our data and an accurate analysis of the current literature lead us to propose the hypothesis that in the impaired nitrogen metabolism following cirrhosis there are neither single metabolic presentations nor many perturbations, but numerous 'subpopulations' of patients who present a homogeneous pattern of alterations that may distinguish them in terms of therapeutic approach.